Table 3.
Distribution of drug resistance by the human adapted MTBC.
Drug | Total (1480) | MTBSS (1208) | MAF (272) | p-value | 95% CI |
---|---|---|---|---|---|
INHr | 109; 7.4% | 90; 7.5% | 19; 6.9% | 0.8979 | 0.63–1.89 |
RIFr | 9; 0.6% | 9; 0.7% | 0; 0.0% | 0.3794 | 0.44–Inf |
MDR | 40; 2.7% | 30; 2.5% | 10; 3.7% | 0.2988 | 0.31–1.55 |
ANYr | 158; 10.7% | 129; 10.7% | 29; 10.7% | 0.9999 | 0.65–1.59 |